Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Overview of attention for article published in Breast Cancer Research and Treatment, December 2011

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

patent: 1 patent

Citations

dimensions_citation: 288 Dimensions

Readers on

mendeley: 226 Mendeley
citeulike: 2 CiteULike

Summary Patents Dimensions citations

So far, Dimensions has found 288 publications that cite this research output.

288

The most recent citing publications are shown below. View all 288 publications that cite this research output on Dimensions.

Optical imaging reveals chemotherapy-induced metabolic reprogramming of residual disease and recurrence

Article in Science Advances (April 2024)

Pathological complete response and associated factors in breast cancer after neoadjuvant chemotherapy: A retrospective study

Article in Turkish Journal of Surgery (March 2024)

Txnrd1 as a prognosticator for recurrence, metastasis and response to neoadjuvant chemotherapy and radiotherapy in breast cancer patients

Article in Heliyon (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.